TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.

Michael D Prados et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.